Eckert & Ziegler SE

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

S56898570
SEDOL

5689857
CIK

N/A

ezag.com
LEI: 391200EUDABLUKXCKG48
New: Infographics X-Lab
FIGI: BBG000BSBF36
EUZ

Eckert & Ziegler SE
GICS: 35101010 · Sector: EQTY · Sub-Sector: -
AI
PROFILER
NAME
Eckert & Ziegler SE
ISIN
DE0005659700
TICKER
EUZ
MIC
XETR
REUTERS
EUZG.DE
BLOOMBERG
EUZ GR
F&G: 56
24.133,72 DAX · 17,30 Vola-Index · 116.482,01 BTC · 1,16553 EURUSD
FOR INVESTORS
FOR TRADERS
Securities Trading
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Fri, 08.08.2025

2nd Quarter 2025: Sales: € 80.6 Mio. million (PY: € 77.8 million) EBIT before special items: € 19.2 million (PY: € 17.5 million) Net income: € 11,7 million (PY: € 9.5 million) 1st Half Year 2025: Sales: € 148.8 million (PY: € 145.4 million) EBIT before special items: € 35.4 million (PY: € 32.5 million) Net income: € 21.4 million (PY: € 18.0 m...
Tue, 05.08.2025

Berlin, 5 August 2025. All formal requirements of the stock split resolved by the Annual General Meeting on 18 June 2025 have now been met and the timeline for implementation of this capital measure of Eckert & Ziegler SE (ISIN DE0005659700) on the bank side is set. Accordingly, the company's shareholders will be entitled to new shares in the r...
Tue, 29.07.2025

Berlin, Germany, 29 July 2025. Eckert & Ziegler (ISIN DE0005659700) has entered a Master Service Agreement with Archeus Technologies (Archeus), a company developing multiple differentiated radiopharmaceutical therapies, for contract manufacturing of its novel investigational compound ART-101. The agreement supports Archeus’ upcoming Phase 1 cli...
Mon, 28.07.2025

Berlin, July 28, 2025. The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) resolved on June 18, 2025, to increase the share capital using company funds by € 42,343,864 to € 63,515,796. The capital increase was entered in the commercial register on 25 July 2025 and thus became effective. As a result, the company's share capital...
Tue, 15.07.2025

Berlin, July 15, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has been recognized by the Berlin Chamber of Industry and Commerce (IHK) for the exceptional quality of its training program for the fourth time in a row. The Berlin-based healthcare company already held the award for “Excellent Training Quality” from 2019 to 2020, from 2021 to 2023...
Wed, 18.06.2025

Berlin, June 18, 2025. The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of EUR 0.50 per share for the 2024 fiscal year. As in the previous year, the Annual General Meeting was held as an in-person event at Eckert & Z...
Thu, 05.06.2025

Berlin, Germany, 05 June 2025. Eckert & Ziegler (ISIN DE0005659700, TecDAX) congratulates Telix Pharmaceuticals Limited (Telix) on the approval of its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection) in Germany, where Eckert & Ziegler Radiopharma GmbH is the official distributor. With...
Fri, 30.05.2025

BOSTON, Mass., 30 May 2025. Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, underscoring its continued leadership in the radiopharmaceutical industry. Building upon the success of the previous editions, this year's event gathered around 100 decision makers, renowned experts, key partners, and influ...
Fri, 23.05.2025

Berlin, May 23, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has once again been honored with the “Best Managed Companies Award”. The award, presented by Deloitte Private, UBS, the Frankfurter Allgemeine Zeitung and the Federation of German Industries (BDI), recognize excellently managed medium-sized companies throughout Germany. Eckert & ...
Tue, 13.05.2025

1st Quarter 2025: Sales of € 68.2 million (previous year: € 67.6 million) EBIT before special items of € 16.2 million (previous year: € 15.0 million) Net income of 9.7 Mio. € (previous year: € 8.5 million)  Forecast 2025: Sales of around € 320 million (confirmed) EBIT before special items of around € 78 million (confirmed)  Berlin, 13 May 2025...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S